Comparison of morrow procedure and transapical beating-heart septal myectomy in patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis

Clicks: 4
ID: 309955
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #45 of 490 articles by views in Frontiers in surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 490 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
IntroductionTransaortic surgical myectomy is the established gold-standard treatment for hypertrophic obstructive cardiomyopathy (HOCM). In contrast, the less invasive transapical beating-heart septal myectomy (TABSM) has recently gained attention as a potential alternative, although comparative evidence regarding their clinical outcomes remains limited.ObjectivesTo compare the efficacy and safety of surgical myectomy and TABSM in patients with HOCM.MethodsA systematic search of PubMed, Web of Science, Cochrane Library, and ScienceDirect (January 2014–May 2025) identified 24 observational studies including 3,732 patients (2,824 surgical myectomy; 908 TABSM). The primary outcome was the change in left ventricular outflow tract pressure gradient (LVOTPG). Secondary outcomes included improvement in NYHA class, prevalence of moderate-to-severe mitral regurgitation (MR ≥ 2), short-term (30-day) and long-term mortality, and the rate of postoperative permanent pacemaker implantation. Random-effects meta-analysis and meta-regression were performed.ResultsBoth procedures achieved substantial and comparable reductions in LVOTG, with no significant between-group difference (p = 0.75). Functional status improved in both cohorts; younger age and higher study quality were independently associated with greater improvement in NYHA class (p < 0.05). Residual MR ≥ grade 2 decreased in both groups. 30-day mortality was low and similar between surgical myectomy and TABSM. Long-term mortality appeared lower after TABSM (≈2%) compared with surgical myectomy (≈6%); however, this finding should be interpreted cautiously due to substantial heterogeneity and shorter follow-up in TABSM studies. Pacemaker implantation occurred less frequently after TABSM than after surgical myectomy (≈2% vs. ≈6%; p = 0.03).ConclusionBoth surgical myectomy and TABSM are effective and safe approaches for septal reduction in HOCM. While surgical myectomy remains the reference standard, TABSM represents a promising minimally invasive option, particularly in anatomically complex or reoperative cases. Prospective studies with standardized endpoints are required to guide individualized procedural selection and confirm long-term outcomes.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251075522, Identifier CRD420251075522.
Reference Key
imported_1768907615_696f635f2eb0a Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Izmailovich, Marina
Journal Frontiers in surgery
Year 2025
DOI
10.3389/fsurg.2025.1666236
URL
https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1666236/full
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.